1. 42PPrediction of PFS using a dynamic assessment of ctDNA in patients with EGFR mutated NSCLC with osimertinib therapy. (7th November 2019) Authors: Moiseenko, F; Stepanova, M; Zhabina, A; Myslik, A; Klimenko, V; Rysev, N; Artemieva, E; Shelekhova, K; Bogdanov, A; Volkov, N; Moiseenko, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 54PInvestigation of the mechanisms of resistance to osimertinib in patients with T790M-associated NSCLC. (7th November 2019) Authors: Stepanova, M; Moiseenko, F; Zhabina, A; Klimenko, V; Rysev, N; Myslik, A; Artemieva, E; Shelekhova, K; Bogdanov, A; Volkov, N; Moiseenko, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗